According to TipRanks.com, Malhorta is a 3-star analyst with an average return of 4.4% and a 55.9% success rate. Malhorta covers the Financial sector, focusing on stocks such as Hudson Pacific Properties, Healthpeak Properties, and Sabra Healthcare REIT.
Currently, the analyst consensus on Ventas is a Moderate Buy with an average price target of $59.06, implying a 12.6% upside from current levels. In a report issued on February 17, Deutsche Bank also maintained a Buy rating on the stock with a $64.00 price target.
Based on Ventas’ latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $1.02 billion and GAAP net loss of $40.85 million. In comparison, last year the company earned revenue of $921 million and had a net profit of $110 million.
Based on the recent corporate insider activity of 88 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of VTR in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Ventas, Inc. engages in the acquisition and ownership of seniors housing and healthcare properties. The company invests in seniors housing and healthcare properties through acquisitions and leases its properties to unaffiliated tenants or operate them through independent third-party managers. It operates through the following segments: Triple-Net Leased Properties, Senior Living Operations, and Office Operations. The company was founded in 1983 and is headquartered in Chicago, IL.
Read More on VTR:
- Mizuho Securities Maintains Their Buy Rating on Alexandria Equities (ARE)
- Datto Holding (MSP) Gets a Hold Rating from Mizuho Securities
- Sangamo Biosciences (SGMO) Receives a Hold from Wedbush
- Mizuho Securities Maintains Their Buy Rating on Realty Income (O)
- Robert W. Baird Sticks to Their Hold Rating for Amcor (AMCR)